Cancer Research Institute News

UniSA researchers targeting a new treatment for pancreatic cancer

New drug being trialled for aggressive brain cancer

A new drug candidate has been discovered by the University of South Australia (UniSA) to treat the most lethal form of brain cancer – glioblastoma – which...

Novel 3D printed stents deliver breakthrough treatment for oesophageal cancer

World-first 3D printed oesophageal stents developed by the University of South Australia could revolutionise the delivery of chemotherapy drugs to provide more...

‘Alarmingly high’ vitamin D deficiency in the United Kingdom

Over 50 per cent of Asians living in the UK are severely deficient in vitamin D, leaving them more vulnerable to respiratory infections such as COVID-19 and...

NHMRC Ideas Grant to support the development UniSA-Sementis peanut allergy vaccine

Researchers at UniSA and Sementis are moving a step closer to developing a vaccine for peanut allergy thanks to an NHMRC Ideas Grant that will support a team...

UniSA study finds survivors of child abuse and neglect are dying young

Globally the statistics are daunting. Across countries and communities between 15 and 50 per cent of children are subject to serious abuse and neglect within...

Go (over) easy on the eggs: ‘Egg-cess’ consumption linked to diabetes.

Scrambled, poached or boiled, eggs are a popular breakfast food the world over. Yet the health benefits of the humble egg might not be all they’re cracked up...

Is proton therapy the silver bullet for children with brain cancer?

Channel 7 Children’s Research Foundation supports seven UniSA projects to improve children’s health and wellbeing

The University of South Australia has won almost $550,000 in research funding from the Channel 7 Children’s Research Foundation to support seven research...

Families and researchers work together to shed light on stillbirth and perinatal death

Stillbirth and perinatal death are deeply personal tragedies for families and for many, the loss is compounded when the cause is left undetermined. As we mark...